2009-11-10 00:47:01 -
Acorda Therapeutics, Inc. - Pharmaceuticals & Healthcare - Deals and Alliances Profile - a new market research report on companiesandmarkets.com www.companiesandmarkets.com/Summary-Company-Profile/acorda-thera ..
Acorda Therapeutics, Inc. - Pharmaceuticals & Healthcare - Deals and Alliances Profile
Summary
Acorda Therapeutics, Inc. (Acorda) is a commercial-stage biopharmaceutical company engaged in the development and marketing of therapies to re-establish neurological function in patients suffering with spinal cord injury (SCI), multiple sclerosis (MS) and other disorders of the nervous system. The companys marketed products include Zanaflex Capsules and Zanaflex tablets
which are the short-acting drugs approved for the management of spasticity. Its product candidate, Fampridine-SR has completed the phase III clinical trial. The company is headquartered in New York, United states
The Acorda Therapeutics, Inc. - Pharmaceuticals & Healthcare - Deals and Alliances Profile is an essential source for company data and information. The profile examines the companys key business structure and operations, history and products, and provides summary analysis of its key revenue lines and strategy as well as highlighting the companys major recent financial deals.
Scope
- Provides key company information for business intelligence needs
- Gives information on the companys major recent financial deals including Mergers and Acquisitions, asset transactions, PE/VC deals, equity offerings, debt offerings and partnerships.
- Data is supplemented with details on the companys history, key executives, business description, locations and subsidiaries as well as a list of products and services and the latest available company statement.
Reasons to buy
- A quick ""one-stop-shop"" to understand the company.
- Support sales activities by understanding your customers businesses.
- Qualify prospective partners and suppliers.
- Understand and respond to your competitors business structure, strategy and prospects through.
- Understanding the key deals which have shaped the company.
